Condensed Statement of Changes In Shareholders’ Equity (Unaudited) - 3 months ended Mar. 31, 2021 - USD ($)
|
Class A Common Stock |
Class B Common Stock |
Additional Paid-In Capital |
Accumulated Deficit |
Total |
| Balance at Dec. 31, 2020 |
|
$ 863
|
$ 24,137
|
$ (507)
|
$ 24,493
|
| Balance (in Shares) at Dec. 31, 2020 |
|
8,625,000
|
|
|
|
| Sale of units in initial public offering, less allocation to derivative warrant liabilities |
$ 3,450
|
|
335,336,550
|
|
335,340,000
|
| Sale of units in initial public offering, less allocation to derivative warrant liabilities (in Shares) |
34,500,000
|
|
|
|
|
| Offering costs |
|
|
(19,132,239)
|
|
(19,132,239)
|
| Purchase price of private placement warrants in excess of initial fair value |
|
|
2,280,000
|
|
2,280,000
|
| Class A common stock subject to possible redemption |
$ (3,110)
|
|
(310,977,220)
|
|
(310,980,330)
|
| Class A common stock subject to possible redemption (in Shares) |
(31,098,033)
|
|
|
|
|
| Net loss |
|
|
|
(2,531,919)
|
(2,531,919)
|
| Balance at Mar. 31, 2021 |
$ 340
|
$ 863
|
$ 7,531,228
|
$ (2,532,426)
|
$ 5,000,005
|
| Balance (in Shares) at Mar. 31, 2021 |
3,401,967
|
8,625,000
|
|
|
|